يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Fiebo J.W. ten Kate"', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
    Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study

    المؤلفون: Marjo J. Kerbert, Janny W. den Ouden, Solko W. Scalm, Rene A. A. van Zanten, Hans H. van Lijf, Henk R. van Buuren, Fiebo J.W. ten Kate, Frank H. J. Wolghagen, Richard A. de Vries, Wim C. J. Hop, Egbert W. van der Hoek, Adelbert M. Smit, Gerard P. van Berge-Henegouwen, Hubert J. F. van Hoogstraten

    المساهمون: Internal Medicine, Pathology, Epidemiology, Other departments

    المصدر: Journal of Hepatology, 29, 736-742. Elsevier
    Journal of hepatology, 29(5), 736-742. Elsevier

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cholagogues and Choleretics, medicine.drug_class, Biliary cirrhosis, Placebo-controlled study, Anti-Inflammatory Agents, Azathioprine, Autoimmunity, Placebo, Gastroenterology, Primary biliary cirrhosis, Double-Blind Method, Prednisone, Internal medicine, Medicine, Humans, Hepatology, Bile acid, business.industry, Liver Cirrhosis, Biliary, Ursodeoxycholic Acid, Middle Aged, medicine.disease, Ursodeoxycholic acid, Endocrinology, Treatment Outcome, Drug Therapy, Combination, Female, business, Immunosuppressive Agents, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62c3963291cdac0cfd0e072ea09fa33aTest
    https://doi.org/10.1016/S0168-8278Test(98)80254-7


    أضف إلى المفضلة
  2. 2
    Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

    المؤلفون: J. M. J. I. Salemans, Hillechien Kuiper, Aad C. Hoek, T. Gie Tan, F. H. J. Wolfhagen, Marco C.M. Rijk, Gerard A.J.J. Nix, Marco C. Becx, Henk R. van Buuren, Joost Scherpenisse, Paul H.G.M. Stadhouders, Dennis P.F. van Houte, Paul C. van de Meeberg, Max Schrijver, Adelbert M. Smit, Gerard P. vanBerge-Henegouwen, Wim C. J. Hop, Hubert J. F. van Hoogstraten, Solko W. Schalm, Pieter Spoelstra, Fiebo J.W. ten Kate

    المساهمون: Other departments, Internal Medicine, Radiology & Nuclear Medicine, Epidemiology, Pathology

    المصدر: Journal of hepatology, 29(3), 417-423. Elsevier
    Journal of Hepatology, 29, 417-423. Elsevier

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cholagogues and Choleretics, Bilirubin, medicine.medical_treatment, Cholangitis, Sclerosing, Liver transplantation, Gastroenterology, Drug Administration Schedule, Primary sclerosing cholangitis, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Internal medicine, Ascites, medicine, Humans, Treatment Failure, Survival rate, Netherlands, Chemotherapy, Hepatology, Dose-Response Relationship, Drug, business.industry, Ursodeoxycholic Acid, Middle Aged, medicine.disease, Ursodeoxycholic acid, Survival Rate, chemistry, Evaluation Studies as Topic, Female, medicine.symptom, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61acdb9d685e2ab63f4af65e26d5268bTest
    https://doi.org/10.1016/S0168-8278Test(98)80059-7


    أضف إلى المفضلة
  3. 3
    The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron

    المؤلفون: J. H. Paul Wilson, Wim C. de Bruijn, Maud L. Cleton, Fiebo J.W. ten Kate, Peter D. Siersema, Joannes J.M. Marx, Louk H.P.M. Rademakers

    المصدر: Journal of Hepatology. 23:259-267

    مصطلحات موضوعية: musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, Pathology, Hepatology, biology, business.industry, Uroporphyrinogen III decarboxylase, nutritional and metabolic diseases, medicine.disease, Gastroenterology, Ferritin, chemistry.chemical_compound, Porphyria, Uroporphyrinogen, chemistry, Morphometric analysis, Internal medicine, medicine, biology.protein, Porphyria cutanea tarda, Siderosis, skin and connective tissue diseases, business, Liver pathology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::46083e41131dd121532a5c987661e3d6Test
    https://doi.org/10.1016/s0168-8278Test(95)80004-2


    أضف إلى المفضلة
  4. 4
    Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis?

    المؤلفون: Fery A.L.M. Eskens, F. H. J. Wolfhagen, Egbert W. van der Hoek, Gerard P. van Berge Henegouwen, Jan van Hattum, Joost Scherpenisse, Solko W. Schalm, Richard A. de Vries, Jannie W. den Ouden Muller, Jaap Ferwerda, Henk R. van Buuren, Fiebo J.W. ten Kate

    المصدر: Journal of Hepatology. 22:381

    مصطلحات موضوعية: medicine.medical_specialty, Remission induction, Primary biliary cirrhosis, Hepatology, business.industry, Internal medicine, Disease remission, medicine, medicine.disease, business, Gastroenterology, Ursodeoxycholic acid, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2093841409295db82f65d7870eb60877Test
    https://doi.org/10.1016/0168-8278Test(95)80297-5


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث